Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    

Legislation Filed To Ensure Tennessee Patients Faster Access To Effective Medicine


Tennesseans for Affordable Access to Medicine, a coalition comprised of thousands of patients, healthcare providers and caregivers, today lauded legislation that would allow Tennessee patients faster access to more effective medical treatment as prescribed by their doctor.

The bill, HB1866/SB1935, is sponsored by Sen. Art Swann (R-Maryville) and Reps. Mark Hall (R-Cleveland), Esther Helton (R-East Ridge) and Robin Smith (R-Hixson) and aims to reform step therapy protocols.

"Step therapy can undermine the relationship between doctors and their patients and often prevents patients from getting the medication they need for effective treatment," Sen. Swann said. "This bill just makes sense. It allows patients access to the treatment their doctor believes is best."

"Controlling costs in healthcare is important, but so is ensuring Tennesseans are getting the treatment they need," Rep. Hall said. "I encourage my colleagues to consider the positive impact of this legislation in balancing cost with effective patient care."

The step therapy process, also known as "fail first," is currently used by insurance companies to review the use of prescription drugs in an attempt to control costs. Through step therapy, a patient may be required to try, then fail, on alternative drugs selected by their insurance company before coverage is granted for the drug prescribed by the patient's health care provider. The protocols of this process limit a health care provider's ability to tailor care to individual patient needs.

"The Arthritis Foundation applauds Reps. Hall, Smith, Helton, and Sen. Swann for introducing legislation that will put reasonable patient protections in place so patients can access the most appropriate therapies recommended by their doctors," Kristen Crawford, state director, advocacy and access for the Arthritis Foundation said.

"We are grateful to Sen. Swann and Reps. Hall, Helton and Smith for introducing this bill," Emily Ogden, director of government relations for the American Cancer Society Cancer Action Network (ACS CAN), said. "Delayed access to the right treatment can put patients with serious or chronic illnesses at risk and increase overall health care costs over time."

Step therapy protocols vary widely among insurers, from the number of steps a patient must cycle through, to the duration a patient must try the insurer's selected medication(s) before they can access their healthcare provider's first choice of treatment.

The proposed legislation does not ban the practice of step therapy in Tennessee but provides exceptions when warranted. The legislation puts safeguards in place around the insurance industry practice of "fail first" to ensure that patients have timely access to critical medications without unnecessary interference from insurance companies.

More than 20 states, including Georgia and Virginia, have enacted legislation limiting step therapy in critical situations, while still allowing insurers to use step therapy when it is medically appropriate.


Related Articles:

Recent Articles

THA, TMA, TNA Outline Legislative Priorities

With the Tennessee General Assembly back in full swing, the state's major healthcare associations outline 2020 priorities.

Read More

Cardiac Innovation in Nashville

From transplants to trials, Nashville hospitals are leading the way in cardiac care.

Read More

A Modern Love Story: Where Technology, Healthcare & Construction Go Hand-in-Hand

Technology has changed every aspect of our lives. In fact, I had a healthy laugh a few weeks ago when I showed my children an old rotary phone and, get this, they did not know what it was.

Read More

Reeves/Smith Bill to Prevent Next Generation of Nicotine Addiction Garners Broad Industry Support

In late January, a group of more than 25 organizations from across Tennessee announced their support for legislation that seeks to prevent the next generation of nicotine addicts in the state.

Read More

Physician Spotlight: A Heart for Healing

TriStar Summit cardiologist Kristen Kerr is passionate about education, improving outcomes in women's heart health.

Read More

Heart Monitor

Read More

Ifetroban for Treating DMD-Associated Cardiomyopathy

Following successful preclinical trials and FDA funding, Cumberland Pharmaceuticals is preparing to launch a new Phase II trial of ifetroban to treat cardiomyopathy in Duchenne Muscular Dystrophy patients.

Read More

Endocrine Society Celebrates Progress from Bench to Bedside

Endocrine Society Chief Professional & Clinical Affairs Officer Robert Lash, MD, discusses the field, annual meeting, road shows and more.

Read More

NMGMA: 10 Minute Takeaway

During the January NMGMA meeting, representatives from Fox Fuel and Lovell Communications shared insights on effective communications.

Read More

Bringing Eye Health into Focus in 2020

A recent survey reveals most Americans have key gaps in knowledge of eye health.

Read More

Email Print



legislative issues
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: